{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in alpha-synuclein"
        },
        {
          "HGVS": "NM_004162.4:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_004162.4",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S mutation in LRRK2"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005258"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Transgenic mice",
        "Description": "The study used transgenic mice expressing mutant alpha-synuclein (A53T)."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Aggregation of alpha-synuclein (A53T) observed in dopaminergic neurons."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent transgenic mouse lines were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each brain region was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic mice served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test for categorical data."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No aggregation of alpha-synuclein in dopaminergic neurons.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of alpha-synuclein aggregates in dopaminergic neurons.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells",
        "Description": "HEK293 cells transfected with LRRK2-G2019S plasmid were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004162.4:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of LRRK2-G2019S compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four independent transfections were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each gel had three technical replicates."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test for comparing wild-type and mutant groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 10% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels exceeding 30% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Behavioral Testing",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Drosophila melanogaster",
        "Description": "Flies expressing A53T alpha-synuclein were tested for locomotor activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Reduced locomotor activity in A53T flies compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five independent fly lines were tested."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each test was repeated three times per line."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type flies served as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic flies served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA for comparing locomotor activity across groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Locomotor activity within 15% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Locomotor activity below 30% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}